2021 Pediatric Grand Rounds | Adolescent-Young Adult (AYA) Neuro-Oncology
The adolescent-young adult (AYA) population is an underserved population as the biology of their diseases and ability to tolerate therapy places them in a category that is neither best served by adult or pediatric specialists. They require a dedicated focus that addresses the uniqueness of the disease biologies that afflict this population, as well as an attention to unique issues they face (fertility, school/work, changing responsibilities and identity). Additionally, there are numerous clinical trials to address neuro-oncology as it remains an area of high mortality within oncology.
The purpose of this lecture is to update pediatric oncologists on the current state of adolescent-young adult (AYA) neuro-oncology, by providing an update on the state of current trials as well as pinpointing the unique demands that the AYA population faces.
City of Hope Pediatric Hematology/Oncology physicians, advance practice practitioners, City of Hope staff and research teams.
- Identify indications for eligibility for current and upcoming adolescent-young adult (AYA) neuro-oncology trials.
- Examine the status of the current literature forming the basis of the current AYA neuro-oncology trials.
- Integrate AYA care into neuro-oncology management where appropriate.
- Outline the various types of cultural diversities (gender, age, race, religion, culture, etc.) that relate to demographics, diagnosis and treatment.
Virtual Meeting- Zoom
Kee Kiat Yeo, MD Pediatric Neuro-Oncologist; Director, Adolescent and Young Adult Neuro-Oncology Program; Dana-Farber Cancer Institute / Boston Children's Hospital
Dr. Yeo has indicated that he does not have anything to disclose.
ACCREDITATION STATEMENT: City of Hope is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
CREDIT DESIGNATION: City of Hope designates this live webinar for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The following credit type(s) are being offered for this course:
• AMA PRA Category 1™ 1.0
The following may apply AMA PRA Category 1 Credit™ for license renewal:
Registered Nurses: Nurses may report up to 1.0 credit hours toward the continuing education requirements for license renewal by their state Board of Registered Nurses (BRN). AMA PRA Category 1 Credit™ may be noted on the license renewal application in lieu of a BRN provider number.
Physician Assistants: The National Commission on Certification of Physicians Assistants states that AMA PRA Category 1 Credit™ accredited courses are acceptable for CME requirements for recertification.
- 1.00 AMA PRA Category 1 Credit™City of Hope is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
City of Hope designates this 2021 Pediatric Grand Rounds | Adolescent-Young Adult (AYA) Neuro-Oncology for a maximum of 1.00 AMA PRA Category 1 Credit™ requirements. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
- 1.00 Attendance